期刊文献+

人尿激肽原酶在急性脑梗死大鼠模型中的研究 被引量:1

Research of human urinary kallidinogenase on acute cerebral infarction in rats
下载PDF
导出
摘要 目的探讨人尿激肽原酶对急性脑梗死大鼠模型的作用机制。方法应用线拴法构建大脑中动脉栓塞致急性脑梗死大鼠模型,并随机分为实验组及模型对照组。实验组经腹腔注射人尿激肽原酶(3.5×10-3 PNAU/kg),模型对照组同法予以生理盐水(10ml/kg),应用免疫组化法分别检测两组梗死灶区微血管密度;应用蛋白质印迹杂交检测两组凋亡相关蛋白Bcl-2的表达,应用AO/EB法检测梗死灶区神经细胞的凋亡率。结果实验组MVD(84.450±5.104条/HP)高于模型对照组MVD(57.900±3.370条/HP);实验组的Bcl-2蛋白表达水平明显高于模型对照组;实验组细胞凋亡率较模型对照组明显降低。结论人尿激肽原酶可使大鼠脑梗死灶中微血管密度增加;应用人尿激肽原酶后大鼠脑梗死灶中细胞凋亡蛋白Bcl-2表达明显增加,脑细胞凋亡受到抑制,脑细胞凋亡率降低。 Objective To discuss the mechanism of human urinary kallidinogenase on acute cerebral infarction in rats. Methods By suture method we build the rat model with acute cerebral infarction,were randomly divided the rats into the experimental group and the model control group. The experimental group was injected human urinary kallikrein (3.5 × 10^-3 PNAU/kg) by intraperitoneal injectinon,which model control group was injected physiological saline by intraperitoneal injection (10 ml/kg). Rats were sacrificed 7 days after modeling. We cut issue infarction area through operation,and detected the infarctarea of MVD by immuno histochemical method in experimental group and model control group. We detected the expression of apoptosis relat- ed protein Bcl-2 with the application of Western blot hybridization (Western blot) in experimental group and control group. At the same time,we detected the apoptosis rate of the nerve cells in infarct with the AO/EB method,and statistical analysis was performed using SPSS software. Results MVD in experimental group were 84. 450±5. 104 / HP and 57. 900±3. 370 / HP in control group( P〈0.05 ). Bcl-2 expression in experimental group was higher than that of model control group. The cell apopto- sis rate in experimental group was decreased obviously compared with model control group. Conclusion Experiments bad estab- lished that human urinary kallidinogenase could increase the microvascular density in acute cerebral infarction in rats. Human u- rinary kallidinogenase obviously increased the apoptosis protein expression of Bcl-2 in infarction in rats,and brain cells apoptosis was restrained and brain ceils apoptosis rate reduced.
作者 齐飞 陈金波
出处 《滨州医学院学报》 2015年第4期247-249,265,共4页 Journal of Binzhou Medical University
关键词 人尿激肽原酶 脑梗死 大鼠模型 细胞凋亡 微血管密度 BCL-2 human urinary kallidinogenase, cerebral infarction, rat model, apoptosis,MVD,Bcl-2
  • 相关文献

参考文献7

  • 1Liu M, Wu B, Wang WZ, et al. Stroke in China: epidemiology, prevention, and management strategies[J]. Lancet Neurol, 2013, 6(5) :456-464.
  • 2Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma[J]. N Engl J Med,1991,324(1) :1-8.
  • 3Han BH, Xu D, Choi J,et al. Selective reversible caspase-3 inhib- itor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury [J]. J Biol Chem,2012,277(33):30128-30136.
  • 4Emanueli C, Madeddu P. Angiogenesis therapy with human tis- sue kallikrein for the treatment of isehemie diseases[J]. Areg Mal Coeur Vaiss, 2004,97(6) : 679-687.
  • 5徐恩,缪学琼,林清原,潘英,钟高贤,刘克,谢海峰,詹丽璇.应用磁共振技术观察人尿激肽原酶对急性脑梗死患者脑血流灌注的影响[J].中国脑血管病杂志,2009,6(3):124-128. 被引量:15
  • 6Nagano H, Suzuki T, Tomoguri T, et al. Pharmacological studies on human urinary kallidinogenase (SK2827) :effects on cerebral metabolism[J]. Yakugaku Zasshi, 1993,113 (11) : 825-828.
  • 7Campbell DJ. The kallikrein-kinin system in humans[J]. Clin Exp Pharmacol Physiol, 2001,28 (12) : 1060-1065.

二级参考文献11

  • 1丁德云,吕传真,丁美萍,苏炳华,陈峰.人尿激肽原酶治疗急性脑梗死多中心随机双盲安慰剂对照试验[J].中华神经科杂志,2007,40(5):306-310. 被引量:168
  • 2Shuaib A,Lees K,Lyden P,et al.NXY-059 for acute ischaemic stroke:results of the SAINT II trial[J].N Engl J Med,2007,357(6):562-571.
  • 3Ole-MoiYoi OK,Spragg J,Austen KF.Structural studies of human urinary kallikrein (urokallikrein)[J].Proc Natl Acad Sci USA,1979,76(7):3121-3125.
  • 4Lu HS,Lin FK,Chao L,et al.Human urinary kallikrein.Complete amino acid sequence and sites of glycosylation[J].Int J Pept Protein Res,1989,33(4):237-249.
  • 5Nagano H,Suzuki T,Hayashi M,et al.Effects of a human urinary kininogenase (SK-827) on cerebral microcirculation after glass bead-induced cerebral embolism in rabbits[J].In Vivo,1992,6(5):497-502.
  • 6Nagano H,Suzuki T,Nakamura S,et al.Pharmacological studies on human urinary kallidinogenase (SK-827):cerebral protective effects[J].Yakugaku Zasshi,1993,113(11):803-809.
  • 7Nagano H,Suzuki T,Tomoguri T,et al.Pharmacological studies on human urinary kallidinogenase (SK-827):effects on cerebral metabolism[J].Yakugaku Zasshi,1993,113(11):825-828.
  • 8Nagano H,Suzuki T,Hayashi M,et al.Effects of a human urinary kininogenase (SK-827) on cerebral and cutaneous microcirculation in rabbits[J].In Vivo,1993,7(2):117-119.
  • 9Emanueli C,Madeddu P.Angiogenesis therapy with human tissue kallikrein for the treatment of ischemic diseases[J].Arch Mal Coeur Vaiss,2004,97(6):679-687.
  • 10Xia CF,Yin H,Borlongan CV,et al.Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis[J].Hypertension,2004,43(2):452-459.

共引文献14

同被引文献15

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部